Cyclosporine levels are not helpful
Henry, M.L.; Bowers, V.D.; Fanning, W.J.; Sommer, B.G.; Ferguson, R.M.
Transplantation Proceedings 20(2 Suppl 2: 419-421
1988
ISSN/ISBN: 0041-1345 PMID: 3284086 Document Number: 322965
Document emailed within 1 workday
Related Documents
Jacobs, T.W.; Katz, I.A.; Joffe, I.I.; Stein, B.; Takizawa, M.; Epstein, S. 1991: The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels Transplantation Proceedings 23(6): 3188-3189Salomon, D.; Brunson, M.; Vansickler, J.; Pfaff, W.; Howard, R.; Peterson, J.; Curry, T.; Thompson, R.; Squiers, E. 1991: A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity Transplantation Proceedings 23(1 Pt 2): 1018-1019
Keown, P.A. 1988: Optimizing cyclosporine therapy: dose, levels, and monitoring Transplantation Proceedings 20(2 Suppl 2: 382-389
Yau, J.C.; Brunner, L.J.; Lopez-Berestein, G.; LeMaistre, C.F.; Luke, D.R. 1991: Therapeutic drug monitoring of cyclosporine-lipoprotein levels PharmacoTherapy 11(4): 291-295
Bronster, D.J.; Chodoff, L.; Yonover, P.; Sheiner, P.A. 1999: Cyclosporine levels in cerebrospinal fluid after liver transplantation Transplantation 68(9): 1410-1413
Carrier, M.; Thai, P.; Stewart, D.; Pelletier, L.C. 1994: Do triglyceride and low-density lipoprotein blood levels affect the vascular response to cyclosporine? Transplantation Proceedings 26(5): 2639-2641
Lemoine, A.; Azoulay, D.; Debuire, B.; Bismuth, H. 1994: Relationship between cyclosporine blood levels and early adverse reactions after liver transplantation Transplantation Proceedings 26(5): 2672-2673
Gibbons, S.; Grevel, J.; Reynolds, K.; Ried, M.; Rutzky, L.P.; Kahan, B.D. 1988: Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant recipients Transplantation Proceedings 20(2 Suppl 2: 339-344
Boers, M.; van Rijthoven, A.W.; Goei Thè, H.S.; Dijkmans, B.A.; Cats, A. 1988: Serum creatinine levels two years later: follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patients Transplantation Proceedings 20(3 Suppl 4): 371-375
Hughes, J.R.; Hughes, V.F.; Trull, A.K.; Metcalfe, S.M. 1999: Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine Transplantation 68(4): 583-586
Allegra, A.; Corica, F.; Ientile, R.; Corsonello, A.; Sparacino, V.; Accettola, F.; Caputo, F.; Macaione, S.; Buemi, M. 1998: Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment Magnesium Research 11(1): 11-18
Veremis, S.A.; Maddux, M.S.; Tang, I.Y.; Millner, S.N.; Prasad, R.; Pollak, R.; Mozes, M.F. 1989: Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection Transplantation Proceedings 21(1 Part 2): 1476-1477
Cantarovich, F.; Cantarovich, D.; Touraine, J.L.; Tizado, J.; Castro, L.Z.; Correa, C.; Herman, A.P.; Traeger, J. 1988: Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment Transplantation Proceedings 20(2 Suppl 2): 402-406
Morozumi, K.; Thiel, G.; Albert, F.W.; Banfi, G.; Gudat, F.; Mihatsch, M.J. 1992: Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts Clinical Nephrology 38(1): 1-8
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Dieperink, H.; Kemp, E.; Leyssac, P.P.; Starklint, H.; Wanscher, M.; Nielsen, J.; Jørgensen, K.A.; Faber, V.; Flachs, H. 1986: Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine a concentration Clinical Nephrology 25(Suppl 1): S137-S143
Anderson, J.E.; Morris, R.E.; Blaschke, T.F. 1987: Pharmacodynamics of cyclosporine-ketoconazole interaction in mice. Combined therapy potentiates cyclosporine immunosuppression and toxicity Transplantation 43(4): 529-533
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Mrowietz, U.; Christophers, E. 1988: Effects of cyclosporine a treatment on psoriasis. I: Influence of low-dose cyclosporine on human monocyte function in vitro Transplantation Proceedings 20(3 Suppl 4: 53-57
Przepiorka, D.; Shapiro, S.; Schwinghammer, T.L.; Bloom, E.J.; Rosenfeld, C.S.; Shadduck, R.K.; Venkataramanan, R. 1991: Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease Bone Marrow Transplantation 7(6): 461-465